Table 1.
Number of YLLs by Level 3 causes in 1990 and 2017, and YLL rates and age-standardised YLL rates for 2017 with percentage change between 1990 and 2017, ordered by ranking of top 20 causes of YLLs in 2017
|
Rank of cause of YLLs |
YLLs (in thousands) |
All-age YLL rate per 100 000 people |
Age-standardised YLL rate per 100 000 people |
|||||
|---|---|---|---|---|---|---|---|---|
| 1990 | 2017 | 2017 | Percentage change 1990–2017 | 2017 | Percentage change 1990–2017 | 2017 | Percentage change 1990–2017 | |
| All causes | .. | .. | 8005 (7615 to 8403) | −20·1% (−23·9 to −16·3) | 13 209 (12 566 to 13 866) | −25·1% (−28·6 to −21·5) | 6709 (6384 to 7038) | −49·5% (−52·0 to −47·1) |
| Ischaemic heart disease | 1 (1 to 1) | 1 (1 to 1) | 1028 (957 to 1118) | −35·3% (−39·5 to −30·4) | 1697 (1579 to 1845) | −39·3% (−43·3 to −34·8) | 690 (640 to 743) | −60·9% (−63·6 to −58·0) |
| Tracheal, bronchus, and lung cancer | 3 (3 to 3) | 2 (2 to 2) | 602 (564 to 645) | −15·5% (−21·3 to −9·4) | 994 (931 to 1064) | −20·8% (−26·2 to −15·0) | 479 (449 to 512) | −41·2% (−45·2 to −37·1) |
| Alzheimer's disease and other dementias | 6 (6 to 6) | 3 (3 to 4) | 581 (542 to 619) | 75·6% (64·2 to 86·1) | 959 (895 to 1022) | 64·6% (53·9 to 74·5) | 302 (281 to 323) | −15·0% (−20·7 to −9·6) |
| Stroke | 2 (2 to 2) | 4 (3 to 4) | 580 (539 to 640) | −37·7% (−42·1 to −32·6) | 956 (889 to 1056) | −41·6% (−45·7 to −36·8) | 369 (343 to 403) | −64·1% (−66·7 to −61·3) |
| Colon and rectum cancer | 8 (8 to 8) | 5 (5 to 5) | 319 (295 to 345) | 6·2% (−1·9 to 14·8) | 526 (486 to 569) | −0·4% (−8·1 to 7·6) | 245 (226 to 265) | −28·1% (−33·8 to −22·1) |
| Chronic obstructive pulmonary disease | 11 (11 to 13) | 6 (6 to 6) | 252 (233 to 274) | −4·7% (−12·6 to 5·1) | 416 (385 to 452) | −10·6% (−18·1 to −1·5) | 153 (141 to 167) | −45·5% (−50·3 to −39·4) |
| Breast cancer | 9 (9 to 9) | 7 (7 to 7) | 240 (217 to 262) | −12·9% (−21·6 to −4·8) | 396 (358 to 433) | −18·4% (−26·5 to −10·8) | 213 (192 to 233) | −38·2% (−44·3 to −32·4) |
| Diabetes | 10 (10 to 11) | 8 (8 to 8) | 226 (210 to 243) | −16·1% (−22·8 to −9·4) | 372 (346 to 401) | −21·4% (−27·6 to −15·1) | 155 (144 to 167) | −46·9% (−51·1 to −42·5) |
| Cirrhosis and other chronic liver diseases | 5 (5 to 5) | 9 (9 to 10) | 214 (193 to 234) | −47·8% (−52·8 to −42·8) | 354 (318 to 387) | −51·1% (−55·7 to −46·4) | 185 (166 to 203) | −63·2% (−67·0 to −59·4) |
| Pancreatic cancer | 16 (16 to 17) | 10 (9 to 10) | 208 (194 to 226) | 39·3% (28·0 to 51·4) | 344 (320 to 374) | 30·6% (20·0 to 41·9) | 163 (151 to 177) | −3·8% (−11·3 to 4·5) |
| Stomach cancer | 7 (7 to 7) | 11 (11 to 12) | 185 (172 to 200) | −42·9% (−47·2 to −38·5) | 306 (284 to 329) | −46·5% (−50·5 to −42·4) | 144 (133 to 155) | −60·8% (−63·9 to −57·7) |
| Hypertensive heart disease | 19 (19 to 25) | 12 (11 to 20) | 184 (86 to 211) | 44·3% (−17·9 to 64·1) | 304 (141 to 349) | 35·3% (−23·1 to 53·9) | 105 (58 to 119) | −22·9% (−50·8 to −13·3) |
| Liver cancer | 15 (15 to 15) | 13 (12 to 13) | 179 (162 to 199) | −1·2% (−10·8 to 9·3) | 296 (267 to 328) | −7·4% (−16·4 to 2·4) | 141 (127 to 157) | −30·9% (−37·7 to −23·5) |
| Road injuries | 4 (4 to 4) | 14 (13 to 15) | 159 (147 to 170) | −66·3% (−68·5 to −63·6) | 262 (243 to 281) | −68·4% (−70·5 to −65·9) | 264 (246 to 284) | −67·1% (−69·5 to −64·5) |
| Lower respiratory infections | 22 (20 to 22) | 15 (15 to 16) | 140 (129 to 152) | 21·4% (9·9 to 33·3) | 231 (213 to 251) | 13·8% (3·0 to 25·0) | 108 (100 to 117) | −41·8% (−48·5 to −35·0) |
| Chronic kidney disease | 20 (18 to 20) | 16 (14 to 17) | 139 (129 to 150) | 12·3% (4·1 to 22·0) | 230 (214 to 247) | 5·3% (−2·4 to 14·3) | 89 (83 to 96) | −37·4% (−42·0 to −32·1) |
| Self-harm | 14 (14 to 14) | 17 (16 to 18) | 137 (126 to 150) | −27·1% (−33·4 to −19·9) | 226 (208 to 247) | −31·6% (−37·6 to −24·9) | 192 (177 to 210) | −32·3% (−38·3 to −25·7) |
| Leukaemia | 18 (17 to 18) | 18 (17 to 19) | 132 (122 to 142) | −9·6% (−16·7 to −2·3) | 217 (201 to 235) | −15·3% (−22·0 to −8·4) | 137 (126 to 149) | −36·2% (−41·7 to −30·2) |
| Prostate cancer | 27 (23 to 28) | 19 (14 to 18) | 114 (97 to 179) | 23·7% (7·0 to 62·7) | 189 (161 to 295) | 16·0% (0·3 to 52·5) | 72 (61 to 116) | −24·2% (−35·0 to 1·2) |
| Other malignant neoplasms | 21 (21 to 24) | 20 (21 to 22) | 100 (83 to 113) | −14·4% (−24·4 to 10·5) | 165 (137 to 186) | −19·8% (−29·2 to 3·5) | 107 (89 to 124) | −34·4% (−43·4 to −13·3) |
Data in parentheses are 95% uncertainty intervals. YLLs=years of life lost.